This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Fluticasone Salmeterol MDPI
Teva Pharmaceutical Industries Ltd.
Drug Names(s): Fluticasone/Salmeterol Spiromax Inhalation Powder, Fluticasone/Dalmeterol MDPI, fluticasone/salmeterol multi-dose powder inhaler
Fluticasone and Salmeterol MDPI is a new formulation of this combination using Teva's multi-dose powder inhaler device, with an enhanced lung delivery that is designed to allow lower doses to achieve the same clinical outcomes as Advair Diskus.
BioMedTracker has a separate profile for this combination using the metered dose inhaler, seen under Fluticasone and Salmeterol (MDI).
Fluticasone Salmeterol MDPI News
Additional information available to subscribers only: